Ductal Carcinoma In Situ and Bilateral Atypical Ductal Hyperplasia in a 23-Year-Old Man with Gynecomastia

被引：0
|
作者：
Gunaydin, Gurcan [1 ]
Altundag, Kadri [1 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, TR-06100 Ankara, Turkey
来源：
AMERICAN SURGEON | 2011年 / 77卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1272 / 1273
页数：2
相关论文
共 50 条
  • [41] COMPARATIVE ULTRASTRUCTURE OF ATYPICAL DUCTAL HYPERPLASIA, INTRADUCTAL CARCINOMA, AND INFILTRATING DUCTAL CARCINOMA OF BREAST
    GOLDENBERG, VE
    GOLDENBERG, NS
    SOMMERS, SC
    CANCER, 1969, 24 (06) : 1152 - +
  • [42] Atypical Ductal Hyperplasia and Those Bordering on Ductal Carcinoma In Situ Should Be Included in the Active Surveillance Clinical Trials
    Khoury, Thaer
    Jabbour, Nashwan
    Peng, Xuan
    Yan, Li
    Quinn, Marie
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (01) : 131 - 138
  • [43] Atypical Ductal Hyperplasia and Those Boarding on Ductal Carcinoma in Situ Should be Included in the Active Surveillance Clinical Trials
    Khoury, Thaer
    Jabbour, Nashwan
    Peng, Xuan
    Yan, Li
    Quinn, Marie
    MODERN PATHOLOGY, 2019, 32
  • [44] Atypical Ductal Hyperplasia and Those Boarding on Ductal Carcinoma in Situ Should be Included in the Active Surveillance Clinical Trials
    Khoury, Thaer
    Jabbour, Nashwan
    Peng, Xuan
    Yan, Li
    Quinn, Marie
    LABORATORY INVESTIGATION, 2019, 99
  • [45] INVASIVE DUCTAL CARCINOMA IN 58-YEAR OLD MAN
    Eftimova, Biljana
    Lazarova, Biljana
    ANNALS OF ONCOLOGY, 2009, 20 : 14 - 14
  • [46] Chemoprevention uptake among women with atypical hyperplasia, lobular and ductal carcinoma in situ
    Coe, A. M.
    Trivedi, M. S.
    Vanegas, A.
    Kukafka, R.
    Crew, K. D.
    CANCER RESEARCH, 2017, 77
  • [47] Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ
    Trivedi, Meghna S.
    Coe, Austin M.
    Vanegas, Alejandro
    Kukafka, Rita
    Crew, Katherine D.
    CANCER PREVENTION RESEARCH, 2017, 10 (08) : 434 - 441
  • [48] Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ
    Martinez, Anthony P.
    Cohen, Cynthia
    Hanley, Krisztina Z.
    Li, Xiaoxian
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (07) : 686 - 689
  • [49] The Utilities of Estrogen Receptor, Cytokeratin 5/6, and Cytokeratin 903 to Differentiate Between Usual Ductal Hyperplasia, Flat Epithelial Atypia, Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Lobular Carcinoma In Situ
    Wei, Eric
    Dela Cruz, Nestor
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S30 - S30
  • [50] A 47-year-old woman with ductal carcinoma in situ
    Morrow, M
    Daley, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (01): : 61 - 66
12345